Abstract
The 1H-15N 2D NMR correlation spectrum of the widely studied FK506-binding protein FKBP12 (FK506-binding protein of 12 kDa) contains previously unreported peak doublings for at least 31 residues that arise from a minor conformational state (12% of total) which exchanges with the major conformation with a time constant of 3.0 s at 43°C. The largest differences in chemical shift occur for the 80′s loop that forms critical recognition interactions with many of the protein partners for the FKBP family. The residues exhibiting doubling extend into the adjacent strands of the β-sheet, across the active site to the α-helix and into the 50′s loop. Each of the seven proline residues adopts a trans-peptide linkage in both the major and minor conformations, indicating that this slow transition is not the result of prolyl isomerization. Many of the residues exhibiting resonance doubling also participate in conformational line-broadening transition(s) that occur ~105-fold more rapidly, proposed previously to arise from a single global process. The 1.70 Å (1 Å=0.1 nm) resolution X-ray structure of the H87V variant is strikingly similar to that of FKBP12, yet this substitution quenches the slow conformational transition throughout the protein while quenching the line-broadening transition for residues near the 80′s loop. Line-broadening was also decreased for the residues in the α-helix and 50′s loop, whereas line-broadening in the 40′s loop was unaffected. The K44V mutation selectively reduces the line-broadening in the 40′s loop, verifying that at least three distinct conformational transitions underlie the line-broadening processes of FKBP12.
Keywords: conformational dynamics, FK506-binding protein of 12 kDa (FKBP12), NMR, slow exchange, X-ray structure
Abbreviations: CPMG, Carr–Purcell–Meiboom–Gill; CT-HSQC, constant-time heteronuclear single-quantum coherence; FKBP12, FK506-binding protein of 12 kDa; mTOR, mammalian target of rapamycin; NOE, nuclear Overhauser effect; RyR, ryanodine receptor; TCEP, tris-(2-carboxyethyl)phosphine
INTRODUCTION
The immunophilin FKBP12 (FK506-binding protein of 12 kDa) was first characterized for its role in binding the immunosuppressants FK506 and rapamycin. The FK506-bound FKBP12 forms a ternary complex with calcineurin that inhibits the protein phosphatase activity of that enzyme which, in turn, blocks a key T-cell activation pathway involved in tissue transplant rejection [1]. In complex with rapamycin, FKBP12 binds to and inhibits the protein kinase mTOR (mammalian target of rapamycin) [2]. The major role of mTOR in regulating cell growth and cancer progression has greatly stimulated the analysis of this interaction with the rapamycin–FKBP12 complex.
Biochemical isolation of the RyR (ryanodine receptor) Ca2+ channels from skeletal muscle demonstrated that four molecules of FKBP12 are bound to each tetrameric RyR1 receptor [3]. Analogous isolation of the cardiac ryanodine receptor RyR2 revealed the binding of the highly homologous FKBP12.6 protein [4]. Although most subsequent studies have been interpreted in terms of distinct regulation of skeletal muscle RyR1 by FKBP12 and cardiac muscle RyR2 regulation by FKBP12.6, a number of studies have pointed to a more complex pattern of interactions. FKBP12 germline knockout mice die in utero due to severe cardiac ventricular defects [5], although mouse cardiomyocyte-specific conditional gene knockout studies appear to indicate a non-cardiomyocyte origin for these ventricular defects [6]. Nevertheless, cardiomyocyte-restricted overexpression of FKBP12 results in cardiac pathologies leading to a high incidence of sudden death [6]. Recent studies point to a more substantial and partially antagonistic role for FKBP12-mediated calcium regulation in cardiac muscle [7].
The peptidylprolyl isomerase activity of FKBP12 appears to play a more central role in its involvement in neurodegeneration arising from protein aggregation pathologies. Not only is FKBP12 found along with the aggregated α-synuclein in the Lewy body deposits of Parkinson's disease patients [8], but also it accelerates the aggregation of α-synuclein in vitro [9] and in vivo [10]. The accumulation of FKBP12 in the neurofibrillary tangles of Alzheimer's disease suggests an analogous binding to the conformationally disordered tau protein [11]. Similarly, the binding of FKBP12 to the amyloid precursor protein, confirmed by both yeast two-hybrid and co-immunoprecipitation [11,12], is selectively disrupted by addition of the FK506 inhibitor.
Continuing interest in FKBP12 as a target for clinical therapies is indicated by the deposition of over 30 X-ray structures of the wild-type and mutational variants of the human protein both free and bound to either small-molecule inhibitors or in physiological protein–protein complexes. Generally, these structures have indicated that only modest changes in the conformation of FKBP12 are induced by these binding interactions. On the other hand, NMR relaxation studies have demonstrated that a substantial number of residues of the unligated protein undergo conformational transition(s) in the microsecond–millisecond timeframe which gives rise to a characteristic line-broadening for the resonances of the neighbouring atoms. Brath, Akke, Yang, Kay and Mulder [13] reported 13C relaxation dispersion measurements of FKBP12 that identified 12 exchange-broadened methyl resonances which they interpreted as representing a single global conformational exchange process with a time constant of ~130 μs. On the basis of the fact that many of these methyl-bearing residues line the active site and correspond to positions that undergo changes in chemical shift upon the binding of FK506 or rapamycin, the authors proposed that these conformational dynamics are functionally significant. Subsequently, Brath and Akke [14] carried out an analogous 15N relaxation dispersion study to characterize conformational dynamics in the backbone of FKBP12. The 23 amides that exhibited conformational exchange primarily lay within the backbone segments of residues 26–44, 53–57 and 75–98 which when combined with their earlier 13C measurements were fitted to a single global time constant of 120 μs.
These line-broadening effects arise from individual nuclei rapidly transferring between conformations that exhibit different 15N (or 13C) chemical shifts. Although the minor conformations do not give rise to distinct observable resonances, when the exchange rates and populations are within suitable ranges, the chemical shifts for the minor conformation can be inferred [15]. Brath and Akke [14] argued that their proposed collective transition corresponds to the catalytic transition state conformation of the enzyme, despite the fact that they observed an absence of any correlation between the magnitude of the ligand-induced shifts and the resonance line-broadening for the various affected residues. Their observation that the binding of FK506 quenches the conformational exchange broadening of the backbone resonances was subsequently verified by Sapienza, Mauldin and Lee [16]. More surprisingly, the latter authors found that, although rapamycin also suppressed the conformational exchange broadening of the backbone resonances in the residue segments 53–57 and 75–98, the exchange broadening for the 26–44 segment becomes more extensive, extending back to residue 23.
To gain further insight into the conformational processes exhibited by FKBP12, we have applied a combination of NMR measurements, crystallographic analysis and structure-based mutagenesis.
EXPERIMENTAL
Protein preparation
Genes for the wild-type as well as C22V, C22V+H87F, C22V+H87V and C22V+K44V variants of human FK506-binding protein were chemically synthesized (Genscript) from the wild-type gene sequence, with codon optimization for expression in Escherichia coli. The gene for the C48L variant of the (Saccharomyces cerevisiae) FKBP12 sequence as given in the crystal structure [17] was similarly produced. The genes were cloned into the expression vector pET11a and then transformed into the BL21(DE3) strain (Novagen) for expression. All expression strains were grown in minimal medium containing 0.1% 15NH4Cl as a nitrogen source, as described previously [18]. For U-13C,15N-enriched samples, 0.2% [U-13C]glucose (Cambridge Isotopes) was substituted for the unlabelled glucose used for preparing the U-15N samples. The U-2H,15N-enriched samples were prepared using [U-2H]glycerol (Cambridge Isotopes) as carbon source in a 2H2O-containing minimal medium as described previously [18].
The cells were grown at 37°C to a D600 of 0.5 before cooling to 25°C and then inducing with 0.5 mM IPTG to a D600 of 0.7. Following overnight agitation at 25°C, the cells were pelleted by centrifugation and frozen at −80°C. Cell lysis and ammonium sulfate fractionation followed by Sephadex G-50 gel exclusion and SP Sepharose FF ion-exchange chromatography were carried out as described previously [19]. For the purification of wild-type FKBP12, 1 mM DTT was added to all buffers.
Following purification, solid Tris base was added to the U-2H,15N-enriched protein samples to obtain a pH above 9, and the samples were incubated at 25°C for at least 3 h to back-exchange the slowly exchanging amide sites. For wild-type FKBP12, 1 mM TCEP [tris-(2-carboxyethyl)phosphine] was added for this exchange step. All protein samples were concentrated via centrifugal ultrafiltration and then equilibrated into a pH 6.5 buffer containing 25 mM sodium phosphate (with 2 mM DTT and 2 mM TCEP for the wild-type protein) by a series of centrifugal concentration steps. A final protein concentration of 1 mM was used for the NMR relaxation experiments. For the crystallization trials, the H87V protein sample was neutralized and then equilibrated into 5 mM sodium chloride and concentrated by centrifugal ultrafiltration.
NMR spectroscopy
NMR data were collected on a Bruker Avance III 600 MHz spectrometer, a Bruker Avance II 800 MHz spectrometer and a Bruker Avance II 900 MHz spectrometer at 25°C. Backbone resonance assignments were carried out using standard HNCO [20], HN(CA)CO [20], HNCACB [21] and HN(CO)CACB [22] experiments. Side-chain resonance assignments utilized 2D CT-HSQC (constant-time heteronuclear single-quantum coherence) [23], 3D HCCH-TOCSY [24] and 3D HCCCONH [25,26] experiments. Chemical shift assignments for the major and minor slow exchange states have been deposited in the BMRB (Biological Magnetic Resonance Bank) under accession numbers 19240 and 19241 respectively. Minor adaptations of standard T1, T2 and heteronuclear NOE (nuclear Overhauser effect) experiments [27] were utilized. The NOE sequence incorporated the optimized 1H saturation protocol proposed by Ferrage, Cowburn, Ghose and colleagues [28]. T1 relaxation delay periods of 0.05, 0.15, 0.25, 0.40, 0.15, 0.60, 0.85, 1.20, 0.60 and 1.60 s were used. To minimize 15N offset effects on the derived T2 values, measurements for CPMG (Carr–Purcell–Meiboom–Gill) periods of 17, 34, 51, 68, 85 and 102 ms were repeated at equally spaced 15N carrier frequencies (four sets at 600 and six sets at 800). For each resonance, the fitted exponentials for each set were then averaged according to the 15N offset using a linear weighting varying from 1.0 on resonance to 0.0 at an offset equal to 15% of the 15N B1 field strength for the CPMG pulses. Error estimates for the NOE measurements were obtained from the difference between two independent datasets. Uncertainties for the T1 time constants were derived from covariance analysis of the fitted exponential (Origin 8.6, OriginLab). T2 error estimation for each resonance lying within the range of carrier frequencies used in these measurements was derived from the set of fitted exponentials used to obtain the individual averaged T2 values. FELIX software (Felix NMR) was used for NMR data processing, and Fast Modelfree software [29] was used for NMR relaxation analysis.
X-ray crystallography
Crystals of the H87V protein were grown at room temperature (22°C) in hanging drops, by mixing 2 μl of protein solution at 21.5 mg/ml concentration with an equal volume of reservoir solution containing 1.7 M sodium malonic acid, 0.1 M Hepes (pH 7.4) and 5% 2-methyl-2,4-pentanediol. The crystals belong to space group C2 with cell parameters a=70.55 Å (1 Å=0.1 nm), b=35.95 Å, c=40.92 Å and β=95.89°. There is one molecule per asymmetric unit, with a crystal solvent content of 48%. Before data collection, crystals were gradually transferred to a reservoir solution containing a higher concentration of malonic acid up to 80% at 5% per step, and then flash-cooled under a nitrogen stream at 100 K, and stored in liquid nitrogen. Diffraction data were collected at 100 K using an RAxisIV++ detector and an in-house Rigaku microfocus MicroMax-007 X-ray generator. All of the data were processed and scaled using CrystalClear 1.3.6 software (Rigaku). With the high-resolution structure of FKBP12 (PDB code 2PPN [30]) used as a search model, clear solutions were found with the PHASER molecular replacement program within the PHENIX suite [31]. Structural refinement was carried out using PHENIX. Model rebuilding was carried out using Coot [32]. Figures of crystallographic structures were generated using Chimera software [33].
RESULTS AND DISCUSSION
Extensive NMR resonance doubling in FKBP12 indicative of a slow conformational transition
Previously, we [19] reported amide hydrogen exchange measurements on human FKBP12 in demonstrating that this experimental monitor of the thermodynamic acidity of the backbone peptide groups is acutely sensitive to protein conformation [34]. As we have shown for FKBP12 and several other well-characterized proteins, the amide hydrogen exchange rate data are reasonably robustly predictable from full atom structural models by continuum dielectric methods, and this analysis provides a valuable characterization of the conformational distribution of the protein native state [35–37]. Since these hydrogen exchange measurements utilize mildly basic conditions for extended time periods, we substituted valine for Cys22 of wild-type FKBP12 to circumvent the chemical modifications that can occur at cysteine residues under such conditions. Val22 is found throughout lower eukaryotes with the cysteine substitution not appearing until during the evolution of fish, not long before the divergence of the FKBP12 and FKBP12.6 subfamilies [38]. Model building from the high-resolution X-ray structure of human FKBP12 [30] indicated an internal cavity which readily accommodates the second methyl group of valine without apparent steric conflict.
During the course of our NMR experiments on the C22V variant of FKBP12, we noted a substantial set of minor peaks at approximately 15% of the intensities for the major amide resonances in the standard 1H-15N 2D correlation spectrum. MS analysis indicated a single chemical species, and backbone resonance assignment experiments on a U-13C,15N-labelled sample enabled us to establish the sequential connectivities for these minor cross-peaks, as illustrated for the residue sequence Thr85–His87 (Figure 1). This evidence for extensive doubling of the amide resonances was quite surprising given that such an effect has been unreported in not only each of the relaxation studies discussed above, but also for a number of other publications presenting 1H-15N 2D correlation spectra of the unligated wild-type FKBP12 in which no such minor peaks are indicated [39–44]. On the other hand, two publications have presented 1H-15N 2D correlation plots of FKBP12 at apparently lower contour levels that indicate a pattern of minor peaks [45,46], although no discussion of this heterogeneity was offered. On the other hand, the initial resonance assignment study by Rosen et al. [39] reported peak doubling for the Hα of Ala84 and for one of the two Hα peaks of Gly58. During the course of their histidine pH titration study, Yu and Fesik [47] also reported a doubling for the Hϵ-Cϵ cross-peak of His87.
To gain further insight into this issue, we prepared a U-2H,15N-enriched sample of wild-type FKBP12 which yielded a well-resolved 1H-15N 2D correlation spectrum in which 31 of the 99 backbone amides and the indole side chain of Trp59 give rise to both major and minor resonances (Figure 2). Excluding significantly overlapped and severely broadened resonances, the mean peak volume ratio between the corresponding minor and major peaks was 14% with an RMSD of 2%, indicating that 12% of the protein adopts this minor conformational state. A corresponding analysis for the C22V variant yielded a similar mean peak volume ratio. The 31 residues that exhibit resonance doubling form not only the majority of the active site, but also span much of the rest of the protein structure (Figure 3).
The largest chemical shift differences for the doubled resonances are seen for the non-proline residues in the 80′s loop which extends from the 310 turn (Pro78–Ala81) to the start of the final β5 strand at Leu97. The residues in this loop provide the large proportion of interprotein interactions in the crystal structures of complexes formed by FKBP12 with calcineurin [48], mTOR [49] and tissue growth factor β1 receptor [50]. The 80′s loop has been noted to exhibit a wider diversity of conformations than the rest of the protein between different structures of FKBP12 as well as among structures of the various FKBP modules of the larger members of this protein family for which this loop has also been implicated in critical protein recognition interactions [51].
The resonance doubling extends beyond the 80′s loop into the first two residues of the β5 strand and the contiguous residues of the adjacent β2 and β3α strands. The doubling also extends backwards along the chain into the 310 turn and into the nearby α-helix bearing Trp59. Given the evidence for a single collective conformational transition underlying these resonance doublings as discussed below, the dynamic coupling between the 80′s loop and the α-helix may in part be mediated by the interactions of the large indole ring of Trp59 at the base of the active-site cleft. In addition, in the 0.92 Å X-ray structure of wild-type FKBP12 [30], the carbonyl oxygens of Tyr80 and Ala81 in the 310 turn form a pair of hydrogen bonds to the amide hydrogens of Gly58 and Arg57 in the first turn of the α-helix respectively (the latter hydrogen bond is mediated by a crystallographic water molecule). Furthermore, the side chain of Ile56 is tightly packed against the aromatic ring of Tyr82.
The resonance doubling extends further to the beginning of the 50′s loop that surrounds the C-terminal end of the α-helix. In addition to the possibility of dynamical coupling mediated through the backbone interactions of the α-helix, the side chain of Glu60 forms hydrogen-bonding interactions with several peptide groups of the 50′s loop that are mediated by a conserved buried water molecule, as analysed in detail in the recent high-resolution crystallographic analysis of FKBP12 [30].
Exchange spectroscopy of the slow conformational transition in FKBP12
A series of zz-exchange experiments were carried out to determine the rate of interchange between conformations giving rise to the doubling of resonances. Although most commonly used to measure 1H-1H cross relaxation rates between protons within 5–6 Å (in this case referred to as the NOESY experiment), this approach was initially introduced for measuring chemical exchange processes near the slow limit of exchange [52]. If the rate of chemical/conformational exchange (kex) is comparable with the 1H longitudinal relaxation rate R1 or higher, the transition rate for a two-state process can be determined by fitting to the population equations:
where PA and PB are the populations of the two states.
Since sufficiently rapid transition rates were only observed at elevated temperatures, the moderately long collection times precluded the use of the less stable wild-type FKBP12, which precipitated under the conditions of these zz-exchange experiments despite the presence of both DTT and TCEP reducing agents. As illustrated for the indole side chain of Trp59 in a U-2H,15N-enriched sample of the C22V variant (Figure 4A), the two diagonal peaks arise from magnetization of the 1H nuclei that remain in the same conformational state at both the beginning and the end of the exchange mixing period, whereas the two off-diagonal cross-peaks arise from nuclei that change conformational state during that mixing period. When the intensity of these peaks are plotted against each other as a function of the exchange mixing period at 43°C, an exchange lifetime of 3.0 s is obtained (Figure 4B). A similar set of exchange measurements at 48°C yielded a conformational transition lifetime of 1.8 s, corresponding to an activation energy of 70 kJ/mol. A linear extrapolation to 25°C predicts a conformational transition lifetime of 20 s. The timeframe for this slow conformational exchange giving rise to resonance doublings is 100-fold longer than the global folding reaction of FKBP12 under similar conditions, with a rate of 4 s−1 at 25°C [53].
Absence of prolyl isomerization in the slow conformational transition of FKBP12
For a number of proteins, slow conformational exchange between doubled resonances have been found to arise near sites in which the torsion angle of a disulfide bond flips from +90 o to −90 o [54,55] or an Xaa-Pro peptide bond undergoes a cis–trans isomerization [56,57]. Although FKBP12 lacks a disulfide linkage, the seven proline residues present the opportunity for a rate-limiting peptide isomerization in the native state. The most robust approach to characterizing the prolyl isomeric state in solution exploits the dependence of the Cβ and Cγ chemical shifts on the equilibrium of the proline ring pucker distribution which, in turn, depends upon the cis–trans equilibrium of the peptide linkage [58]. Across a large number of proteins of known structure, the difference between the Cβ and Cγ chemical shifts for trans-proline residues averaged 4.51 p.p.m. with an S.D. of 1.17 p.p.m. [59]. The corresponding values for cis-proline residues were 9.64 p.p.m. and 1.27 p.p.m. respectively.
A 2D CT-HSQC experiment resolved the 1Hδ-13Cδ resonances of wild-type FKBP12 for the major slow exchange state of all seven proline residues and for the minor slow exchange state of Pro88 and Pro92 (Supplementary Figure S1 at http://www.biochemj.org/bj/453/bj4530371add.htm). 2D planes from a 3D (H)CCH-TOCSY experiment yielded connectivity patterns linking the 13Cδ resonance of each proline to the intraresidue Cα, Cβ and Cγ resonances (Figure 5). In every case, the difference between the Cβ and Cγ chemical shifts is close to 4.5 p.p.m. (4.0 p.p.m. for both Pro88 and Pro92 in the minor state), indicating that all proline residues remain in a trans conformation in both the major and minor slow exchange states. Particularly noteworthy is the 5.7 p.p.m. upfield shift of the Pro88 Cα resonance that occurs upon transition into the minor slow exchange state (Figure 5). Similarly large changes in chemical shift occur for the 15N and 13Cα resonances of Gly89. Chemical shift analysis of the backbone resonances with the TALOS+ algorithm [60] predicts Φ and Ψ torsion angles of (88, −7) for Gly89 in the major slow exchange state {X-ray structure [30] yields (103, −28)}, while torsion angles of (−59, −27) are predicted for the minor slow exchange state. These results suggest that the switch from a positive to a negative Φ angle for Gly89 constitutes a major aspect of the structural transition underlying the resonance doubling behaviour of FKBP12.
Magnetic field-dependence of 15N NMR relaxation in characterizing conformational exchange-induced line-broadening in FKBP12
The timeframe for the slow conformational exchange differs by five orders of magnitude from that for the fast limit line-broadening transition (τ≈100 μs) [13,14] discussed above. Nevertheless, there are noteworthy similarities between the set of residues involved in these two classes of transitions. For conformational transitions in the fast limit regime of NMR exchange broadening (τ≈20–500 μs), the increase in the transverse relaxation rate R2 arising from these conformational dynamics scales as the square of the magnetic field as illustrated for the major conformer 15N resonances of the wild-type and the C22V variant of FKBP12 at 14.1 T (1H 600 MHz) and 18.8 T (1H 800 MHz) (Figure 6). The majority of residues yield similar R2 values near 8 s−1 at 600 MHz and 10 s−1 at 800 MHz, which combined with the corresponding R1 longitudinal relaxation times and NOE values (Supplementary Figure S2 at http://www.biochemj.org/bj/453/bj4530371add.htm), are consistent with an isotropically tumbling global correlation time of 5.8 ns. A protein concentration of 1 mM was used in these measurements, as we observed an appreciable increase in the R2 values for higher concentrations.
As expected, the residues of wild-type FKBP12 that exhibit a significant magnetic field-dependence in their R2 values closely correspond to the residues for which Brath and Akke [14] reported 15N relaxation dispersion curves under similar experimental conditions. Consistent with fast limit exchange dynamics, the exchange contribution to the present R2 relaxation rates closely correlate (r=0.979) with the Φex values that Brath and Akke derived from their relaxation dispersion analysis (Supplementary Figure S3 at http://www.biochemj.org/bj/453/bj4530371add.htm).
A number of the residues that exhibit conformational exchange line-broadening also give rise to resonance doubling. The differences in 15N chemical shift between the major and minor peaks for these residues do not exhibit a strong correlation with the magnitude of the field-dependent 15N R2 line-broadening as could be anticipated if the conformations of the minor states for both the slow and fast transitions were to be structurally similar. A more definitive demonstration of a qualitative distinction between the properties of the slow exchanging (τ≈20 s at 25°C) major and minor species comes from the R2 relaxation rates for the minor species resonances that are sufficiently resolved to enable reliable peak integration. All of these well-resolved minor slow exchange state resonances have R2 values that are quite similar to the R2 values for residues in the major slow exchange state that do not exhibit any conformational exchange broadening (Figure 7, and Supplementary Figure S4 at http://www.biochemj.org/bj/453/bj4530371add.htm). Regarding the spatial extent of this correlation, only half of the residues having a well resolved resonance in the minor slow exchange state also exhibit line-broadening in the major slow exchange state, and all of the residues exhibiting both characteristics lie within the 80′s loop. Thus, at minimum, the slow transition to the minor state conformation results in the quenching of the 105-fold more rapid line-broadening dynamics in the 80′s loop.
The conformational exchange broadening behaviour of the major and minor slow exchange states of the C22V variant closely follows that of the wild-type protein, indicating that the valine substitution has a minimal effect on either of these two distinct dynamic processes. Given the superior chemical stability of the C22V variant, the additional mutations considered below were all introduced into this background.
Modulation of FKBP12 conformational dynamics by mutational studies
As an X-ray structure determination of the yeast (S. cerevisiae) FKBP12 bound to FK506 has been reported [17], we carried out similar NMR measurements on the unligated form of that protein with the intent of gaining structural insight into these two classes of conformational transitions. Immediately apparent was the fact that the set of minor peaks in the yeast protein were attenuated 4-fold from their relative intensity in the human protein (Supplementary Figure S5 at http://www.biochemj.org/bj/453/bj4530371add.htm). The yeast and human FKBP12 sequences are reasonably similar within the 80′s loop which exhibits the largest differential shifts between the major and minor slow exchange states. One noteworthy difference is the presence of phenylalanine in the yeast protein at position 87 (histidine in the human enzyme), which in the crystal structure sticks out into the substrate-binding pocket. When the H87F mutation was introduced into the human FKBP12 sequence, the population of the minor slowing exchanging state was again attenuated ~4-fold relative to the parental human sequence.
Given that residue 87 plays a significant role in modulating the population of the minor slow exchange state, we analysed the H87V variant of the human protein. Navia and colleagues have reported the X-ray structures of the H87V and H87V+R42K variants of FKBP12 bound to FK506 and deposited the co-ordinates of the double mutant in the PDB (PDB code 1BKF) [61]. They reported that the Cα co-ordinates of the H87V variant have an RMSD of 0.277 Å with respect to their reference native structure. Minimal structural distortion occurs around the site of mutation.
We found that substitution of valine at position 87 dramatically suppresses the minor state of the slow exchange transition. No evidence for any minor state resonance was observed for any of the 31 residues that exhibit doubling in wild-type FKBP12, indicating an upper limit of ~0.2% for the minor state (Figure 8). Given the 12% population of the minor state in wild-type FKBP12, the H87V substitution shifts the equilibrium of the slow exchange transition at least 60-fold or by more than 10 kJ/mol. Such a large effect on the equilibrium of this transition is consistent with the H87V mutation being closely connected to the primary site of structural alteration from which the chemical shift differences discussed above appear to be around the Pro88–Gly89 linkage. On the other hand, as illustrated in the mutational analysis of cis–trans-proline equilibria in staphylococcal nuclease [62], substitutions well removed from the site of proline isomerization can significantly alter the cis/trans ratio. The ratio for the major and minor slow exchange conformations of FKBP12 is unchanged from pH 5.5 to pH 9.0 (pKa of His87 is 5.92 [47]), indicating that the effect of the valine substitution does not arise indirectly from eliminating the ionization of the imidazole side chain.
The R1 and NOE values for the H87V variant are quite similar to those for the major species of the wild-type protein, indicating similar dynamics in the picosecond–nanosecond timeframe. In contrast, the R2 values for the H87V variant differ markedly. The conformational broadening for the residues in the 80′s loop and preceding 310 helix was suppressed completely, whereas the broadened resonances in the 40′s loop were seemingly unaffected (Figure 9). An intermediate behaviour was seen for residues near the beginning of the α-helix. For Glu54, Val55 and Gly58, the conformational broadening contribution decreased ~35% in comparing the H87V variant with either the wild-type protein or the K44V variant discussed below. The decoupling of the conformational broadening dynamics between different regions of the protein induced by the H87V mutation clearly indicates that the apparent global character of the motions in this timeframe proposed in previous relaxation studies [13,14,16] is coincidental.
A complimentary behaviour was observed when valine was introduced at residue 44. The line-broadening from conformational exchange at residues 39, 42 and 44 decreased 3-fold, whereas none of the other amides of the protein were affected (Supplementary Figure S6 at http://www.biochemj.org/bj/453/bj4530371add.htm). More strikingly, none of the resonance doublings exhibited by the wild-type protein were affected by the K44V mutation, including that for the immediately adjacent Ser38. Noteworthy is the close similarity between the resonances for the major exchange state in the 1H-15N 2D correlation spectrum of the K44V variant (Supplementary Figure S7 at http://www.biochemj.org/bj/453/bj4530371add.htm) and those of the H87V variant (Figure 8), indicating how precisely the structure is preserved upon these mutations.
Our NMR relaxation studies of FKBP12 variants demonstrate that the conformational broadening dynamics described previously appear to involve at least three distinct processes centred on the 80′s loop, the 50′s loop + α-helix and the 40′s loop respectively. Motion in the 40′s loop, as indicated by line-broadening at Ser39, Arg42 and Lys44, is dynamically uncoupled from other significant transitions of the protein in this timeframe. A structural basis for the decoupling of these conformational dynamics might be anticipated from the substantial distance between the residues of the 40′s loop and either those of the 80′s loop or of the 50′s loop and α-helix. On the other hand, line-broadening in the 80′s loop is efficiently suppressed by the modest structural alteration of the Val87 substitution, whereas the conformational dynamics of the 50′s loop and the adjacent α-helix are also significantly affected. As considered in the discussion of dynamical coupling for the slow exchange transition above, the direct interactions between residues of the 310 turn at the start of the 80′s loop and Ile56, Arg57 and Gly58 at the start of the α-helix could potentially mediate coupling between these two regions for conformational transition occurring within the line-broadening time regime (τ≈100 μs).
The H87V-induced suppression of line-broadening for many of the residues surrounding the active site does not technically demonstrate that the underlying conformational transition has been suppressed. Formally, the valine substitution could have accelerated the rate of that transition to above ~50000 s−1 so that the line-broadening effect is eliminated. In part due to the attendant elimination of the widespread resonance doubling, a direct suppression of the underlying conformational transition provides a considerably more plausible interpretation. The peptidylprolyl isomerase activity of FKBP12 is unaffected by the substitution of valine at position 87 [61]. This lack of effect on the catalytic activity for a mutation that suppresses the conformational broadening behaviour for much of the active site appears to be inconsistent with the earlier NMR relaxation analysis that ascribed this line-broadening to a sampling of the transition state conformation by the unligated enzyme [14].
At least for residues in the 80′s loop that exhibit resonance doubling as well as conformational exchange broadening for the major slow exchange form, the conformational exchange broadening is suppressed for the minor slow exchange form. A model for rationalizing this behaviour posits that the minor slow exchange state is kinetically accessed via the minor form of the ~100 μs line-broadening transition of the 80′s loop. Substitution of valine at residue 87 inhibits this ~100 μs transition to the minor form which, in turn, precludes the larger scale transition responsible for the extensive resonance doubling.
Crystal structure for the H87V variant of FKBP12
To gain further structural insight into how the H87V substitution so dramatically alters the dynamical properties of the protein, we carried out a crystallographic analysis of this variant protein at 1.70 Å resolution (Table 1, crystallographic summary). Overall, there is a 0.25 Å Cα RMSD between this structure and the 0.92 Å resolution structure of the wild-type protein (PDB code 2PPN [30]). In particular, the minimal differences in structure applies to the region surrounding residue 22 for which the wild-type cysteine residue is replaced by valine. The only appreciable shift in heavy atom position at this site is for Leu103 Cδ1 which moves 0.6 Å away from the newly introduced Val22 Cγ1 methyl group.
Table 1. Crystallographic data collection, refinement and model details (PDB code 4IPX).
Paramater | Value |
---|---|
Data collection | |
Resolution range (Å) | 35–1.70 (1.78–1.70) |
Number of unique reflections | 10996 |
Redundancy | 3.2 (3.4) |
Completeness (%) | 93.7 (93.6) |
Average I/σ(I) | 29.4 (6.3) |
Rmerge (%) | 9.7 (29.6) |
Refinement | |
Resolution limits (Å) | 35–1.70 |
Number of reflections | 10996 |
Rwork (%) | 20.8 |
Rfree (%) | 21.8 |
Non-hydrogen atoms | |
Protein | 830 |
MPD | 16 |
Water | 127 |
Average B-factor (Å2) | |
All atoms | 16.8 |
Solvent | 29.5 |
Geometry | |
RMSD bond length (Å) | 0.003 |
RMSD bond angle (°) | 0.815 |
Beyond the changes in covalent structure caused by substitution of valine for histidine at residue 87, there is strikingly little alteration within this region of the protein (Figure 10). The Cγ1 atom of Val87 lies upon the histidine Cγ atom of the wild-type structure, while the valine Cγ2 projects toward the face of the aromatic ring of Tyr82 which is not displaced but appears to become more constrained. Of the nine aromatic phenylalanine, tyrosine and tryptophan residues in FKBP12, the ring atoms of Tyr82 have the highest average crystallographic B-factor in the wild-type structure, but the lowest average B-factor in the H87V structure (Figure 11). This rigidification of the Tyr82 side-chain mobility is consistent with the reduced conformational dynamics of the Tyr82 backbone that is indicated by the marked narrowing of the amide resonance of this residue in the H87V NMR spectra.
The H87V mutation appears to lock the protein in a conformation closely similar to the major form of wild-type FKBP12. The modest structural changes induced by the substitution of valine for histidine at residue 87 are sufficient to suppress the transition to the minor state of the spatially extensive slow exchange process at least 60-fold. This structurally conservative mutation also serves to suppress the much more rapid conformational line-broadening dynamics in the 80′s loop and partially suppress mobility in this time regime in the region surrounding the start of the α-helix. Further structural analysis of conformational plasticity in the region surrounding the 80′s loop may provide useful insight into the wide range of intermolecular recognition interactions mediated by this loop for the various members of the FKBP family of proteins.
Online data
ACKNOWLEDGEMENTS
We acknowledge the use of the NMR facility, X-ray crystallography and Molecular Genetics cores at the Wadsworth Center as well as the NMR facility at the New York Structural Biology Center.
AUTHOR CONTRIBUTION
Sourajit Mustafi was involved in the design of the study, collection and analysis of the NMR data and in the writing of the paper. Hui Chen was involved in the collection and analysis of the crystallographic data. Hongmin Li supervised and participated in the crystallographic studies as well as in the writing of the paper. David LeMaster prepared the protein samples and participated with Griselda Hernández in the design and supervision of the study, in the collection and analysis of the NMR data and in the writing of the paper.
FUNDING
This work was supported in part by the National Institutes of Health [grant number GM 088214].
References
- 1.Liu J., Farmer J. D., Jr, Lane W. S., Friedman J., Wiessman I., Schreiber S. L. Calcineurin is a common target for cyclophilin–cyclosporin A and FKBP–FK506 complexes. Cell. 1991;66:807–815. doi: 10.1016/0092-8674(91)90124-h. [DOI] [PubMed] [Google Scholar]
- 2.Heitman J., Novva N. R., Hall M. N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 1991;253:905–909. doi: 10.1126/science.1715094. [DOI] [PubMed] [Google Scholar]
- 3.Timerman A. P., Ogunbumni E., Freund E., Wiederrecht G., Marks A. R., Fleischer S. The calcium release channel of sarcoplasmic reticulum is modulated by FK506-binding protein. J. Biol. Chem. 1993;268:22992–22929. [PubMed] [Google Scholar]
- 4.Lam E., Martin M. M., Timerman A. P., Sabers C., Fleischer S., Lukas T., Abraham R. T., O’Keefe S. J., O’Neill E. A., Wiederrecht G. J. A novel FK506 protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor. J. Biol. Chem. 1995;270:26511–26522. doi: 10.1074/jbc.270.44.26511. [DOI] [PubMed] [Google Scholar]
- 5.Shou W., Aghdasi B., Armstrong D. L., Guo Q., Bao S., Charng M. J., Mathews L. M., Schneider M. D., Hamilton S. L., Matzuk M. M. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature. 1998;391:489–492. doi: 10.1038/35146. [DOI] [PubMed] [Google Scholar]
- 6.Maruyama M., Li B. Y., Chen H., Xu X., Song L. S., Guatimosim S., Zhu W., Yong W., Zhang W., Bu G., et al. FKBP12 is a critical regulator of the heart rhythm and the cardiac voltage-gated sodium current in mice. Circ. Res. 2011;108:1042–1052. doi: 10.1161/CIRCRESAHA.110.237867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Galfré E., Pitt S. J., Venturi E., Sitsapesan M., Zaccai N. R., Tsaneva-Atanasova K., O’Neill S., Sitsapesan R. FKBP12 activates the cardiac ryanodine receptor Ca2+-release channel and is antagonised by FKBP12.6. PLoS ONE. 2012;7:e31956. doi: 10.1371/journal.pone.0031956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Avramut M., Achim C. L. Immunophilins and their ligands: insights into survival and growth of human neurons. Physiol. Behav. 2002;77:463–468. doi: 10.1016/s0031-9384(02)00934-4. [DOI] [PubMed] [Google Scholar]
- 9.Gerard M., Debyser Z., Desender L., Baert J., Brandt I., Baekelandt V., Engelborghs Y. FK506 binding protein 12 differentially accelerates fibril formation of wild-type α-synuclein and its clinical mutants A30P or A53T. J. Neurochem. 2008;106:121–133. doi: 10.1111/j.1471-4159.2008.05342.x. [DOI] [PubMed] [Google Scholar]
- 10.Gerard M., Deleersnijder A., Daniëls V., Schreurs S., Munck S., Reumers V., Pottel H., Engelborghs Y., Van den Haute C., Taymans J. M., et al. Inhibition of FK506 binding proteins reduces α-synuclein aggregation and Parkinson's disease-like pathology. J. Neuroscience. 2010;30:2454–2463. doi: 10.1523/JNEUROSCI.5983-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sugata H., Matsuo K., Nakagawa T., Takahashi M., Mukai H., Ono Y., Maeda K., Akiyama H., Kawamata T. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles. Neurosci. Lett. 2009;459:96–99. doi: 10.1016/j.neulet.2009.04.062. [DOI] [PubMed] [Google Scholar]
- 12.Liu F. L., Liu P. H., Shao H. W., Kung F. L. The intracellular domain of amyloid precursor protein interacts with FKBP12. Biochem. Biophys. Res. Commun. 2006;350:472–477. doi: 10.1016/j.bbrc.2006.09.073. [DOI] [PubMed] [Google Scholar]
- 13.Brath U., Akke M., Yang D., Kay L. E., Mulder F. A. A. Functional dynamics of human FKBP12 revealed by methyl 13C rotating frame relaxation dispersion NMR spectroscopy. J. Am. Chem. Soc. 2006;128:5718–5727. doi: 10.1021/ja0570279. [DOI] [PubMed] [Google Scholar]
- 14.Brath U., Akke M. Differential responses of the backbone and side-chain conformational dynamics in FKBP12 upon binding the transition-state analog FK506: implications for transition-state stabilization and target protein recognition. J. Mol. Biol. 2009;387:233–244. doi: 10.1016/j.jmb.2009.01.047. [DOI] [PubMed] [Google Scholar]
- 15.Baldwin A. J., Kay L. E. NMR spectroscopy brings invisible protein states into focus. Nat. Chem. Biol. 2009;5:808–814. doi: 10.1038/nchembio.238. [DOI] [PubMed] [Google Scholar]
- 16.Sapienza P. J., Mauldin R. V., Lee A. L. Multi-timescale dynamics study of FKBP12 along the rapamycin–mTOR binding coordinate. J. Mol. Biol. 2011;405:378–394. doi: 10.1016/j.jmb.2010.10.037. [DOI] [PubMed] [Google Scholar]
- 17.Rotonda J., Burbaum J. J., Chan H. K., Marcy A. I., Becker J. W. Improved calcineurin inhibition by yeast FKBP12–drug complexes: crystallographic and functional analysis. J. Biol. Chem. 1993;268:7607–7609. doi: 10.2210/pdb1yat/pdb. [DOI] [PubMed] [Google Scholar]
- 18.Hernández G., LeMaster D. M. Reduced temperature dependence of collective conformational opening in a hyperthermophile rubredoxin. Biochemistry. 2001;40:14384–14391. doi: 10.1021/bi0112560. [DOI] [PubMed] [Google Scholar]
- 19.Hernández G., Anderson J. S., LeMaster D. M. Polarization and polarizability assessed by protein amide acidity. Biochemistry. 2009;48:6482–6494. doi: 10.1021/bi900526z. [DOI] [PubMed] [Google Scholar]
- 20.Kay L. E., Xu G. Y., Yamazaki T. Enhanced-sensitivity triple-resonance spectroscopy with minimal H2O saturation. J. Magn. Reson., Ser. A. 1994;109:129–133. [Google Scholar]
- 21.Muhandiram D. R., Kay L. E. Gradient-enhanced triple-resonance three-dimensional NMR experiments with improved sensitivity. J. Magn. Reson., Ser. B. 1994;103:203–216. [Google Scholar]
- 22.Yamazaki T., Lee W., Arrowsmith C. H., Muhandiram D. R., Kay L. E. A suite of triple resonance NMR experiments for the backbone assignment of 15N, 13C, 2H labeled proteins with high sensitivity. J. Am. Chem. Soc. 1994;116:11655–11666. [Google Scholar]
- 23.Vuister G. W., Bax A. Resolution enhancement and spectral editing of uniformily 13C-enriched proteins by homonuclear broadband 13C decoupling, J. Magn. Reson. 1992;98:428–435. [Google Scholar]
- 24.Kay L. E., Xu G. Y., Singer A. U., Muhandiram D. R., Forman-Kay J. D. A gradient-enhanced HCCH-TOCSY experiment for recording side-chain 1H and 13C correlations in H2O samples of proteins. J. Magn. Reson., Ser. B. 1993;101:333–337. [Google Scholar]
- 25.Montelione G. T., Lyons B. A., Emerson S. D., Tashiro M. An efficient triple resonance experiment using carbon-13 isotropic mixing for determining sequence-specific resonance assignments of isotopically-enriched proteins. J. Am. Chem. Soc. 1992;114:10974–10975. [Google Scholar]
- 26.Grzesiek S., Anglister J., Bax A. Correlation of backbone amide and aliphatic side-chain resonances in 13C/15N-enriched proteins by isotropic mixing of 13C magnetization. J. Magn. Reson., Ser. B. 1993;101:114–119. [Google Scholar]
- 27.Farrow N. A., Muhandiram R., Singer A. U., Pascal S. M., Kay C. M., Gish G., Shoelson S. E., Pawson T., Forman-Kay J. D., Kay L. E. Backbone dynamics of a free and a phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry. 1994;33:5984–6003. doi: 10.1021/bi00185a040. [DOI] [PubMed] [Google Scholar]
- 28.Ferrage F., Reichel A., Battacharya S., Cowburn D., Ghose R. On the measurement of 15N-{1H} nuclear Overhauser effects. 2. Effects of the saturation scheme and water signal suppression. J. Magn. Reson. 2010;207:294–303. doi: 10.1016/j.jmr.2010.09.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Cole R., Loria J. P. FAST-Modelfree: a program for rapid automated analysis of solution NMR spin-relaxation data. J. Biomol. NMR. 2003;26:203–213. doi: 10.1023/a:1023808801134. [DOI] [PubMed] [Google Scholar]
- 30.Szep S., Park S., Boder E. T., Van Duyne G. D., Saven J. G. Structural coupling between FKBP12 and buried water. Proteins. 2008;74:603–611. doi: 10.1002/prot.22176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Adams P. D., Afonine P. V., Bunkóczi G., Chen V. B., Davis I. W., Echols N., Headd J. J., Hung L.-W., Kapral G. J., Grosse-Kunstleve R. W., et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Emsley P., Lohkamp B., Scott W. G., Cowtan K. Features and development of Coot. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010;66:486–501. doi: 10.1107/S0907444910007493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Pettersen E. F., Goddard T. D., Huang C. C., Couch G. S., Greenblatt D. M., Meng E. C., Ferrin T. E. UCSF Chimera: a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605–1612. doi: 10.1002/jcc.20084. [DOI] [PubMed] [Google Scholar]
- 34.Anderson J. S., Hernández G., LeMaster D. M. Assessing the chemical accuracy of protein structures via peptide acidity. Biophys. Chem. 2013;171:63–75. doi: 10.1016/j.bpc.2012.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.LeMaster D. M., Anderson J. S., Hernández G. Peptide conformer acidity analysis of protein flexibility monitored by hydrogen exchange. Biochemistry. 2009;48:9256–9265. doi: 10.1021/bi901219x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Hernández G., Anderson J. S., LeMaster D. M. Assessing the native state conformational distribution of ubiquitin by peptide acidity. Biophys. Chem. 2010;153:70–82. doi: 10.1016/j.bpc.2010.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Hernández G., Anderson J. S., LeMaster D. M. Experimentally assessing molecular dynamics sampling of the protein native state conformational distribution. Biophys. Chem. 2012;163–164:21–34. doi: 10.1016/j.bpc.2012.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Somarelli J. A., Herrara R. J. Evolution of the 12 kDa FK506-binding protein gene. Biol. Cell. 2007;99:311–321. doi: 10.1042/BC20060125. [DOI] [PubMed] [Google Scholar]
- 39.Rosen M. K., Michnick S. W., Karplus M., Schreiber S. L. Proton and nitrogen sequential assignments and secondary structure determination of the human FK506 and rapamycin binding protein. Biochemistry. 1991;30:4774–4789. doi: 10.1021/bi00233a020. [DOI] [PubMed] [Google Scholar]
- 40.Egan D. A., Logan T. M., Liang H., Matayoshi E., Fesik S. W., Holzman T. F. Equilibrium denaturation of recombinant human FK binding protein in urea. Biochemistry. 1993;32:1920–1927. doi: 10.1021/bi00059a006. [DOI] [PubMed] [Google Scholar]
- 41.Cheng J. W., Lepre C. A., Moore J. M. 15N NMR relaxation studies of the FK506 binding protein: dynamic effects of ligand binding and implications for calcineurin recognition. Biochemistry. 1994;33:4093–4100. doi: 10.1021/bi00180a001. [DOI] [PubMed] [Google Scholar]
- 42.Shuker S. B., Hajduk P. J., Meadows R. P., Fesik S. W. Discovering high-affinity ligands for proteins: SAR by NMR. Science. 1996;274:1531–1534. doi: 10.1126/science.274.5292.1531. [DOI] [PubMed] [Google Scholar]
- 43.Sich C., Improta S., Cowley D. J., Guenet C., Merly J. P., Teufel M., Saudek V. Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamics. Eur. J. Biochem. 2000;267:5342–5354. doi: 10.1046/j.1432-1327.2000.01551.x. [DOI] [PubMed] [Google Scholar]
- 44.Inomata K., Ohno A., Tochio H., Isogai S., Tenno T., Nakase I., Takeuchi T., Futaki S., Ito Y., Hiroaki H., Shirakawa M. High-resolution multi-dimensional NMR spectroscopy of proteins in human cells. Nature. 2009;458:106–109. doi: 10.1038/nature07839. [DOI] [PubMed] [Google Scholar]
- 45.Liu A., Hu W., Majumdar A., Rosen M. K., Patel D. J. Detection of very weak side chain-main chain hydrogen bonding interactions in medium-size 13C/15N-labeled proteins by sensitivity-enhanced NMR spectroscopy. J. Biomol. NMR. 2000;17:79–82. doi: 10.1023/a:1008373501591. [DOI] [PubMed] [Google Scholar]
- 46.Chatterjee A., Bhavesh N. S., Panchal S. C., Hosur R. V. A novel protocol based on HN(C)N for rapid resonance assignment in (15N,13C) labeled proteins: implications to structural genomics. Biochem. Biophys. Res. Commun. 2002;293:427–432. doi: 10.1016/S0006-291X(02)00240-1. [DOI] [PubMed] [Google Scholar]
- 47.Yu L., Fesik S. W. pH titration of the histidine residues of cyclophilin and FK506 binding protein in the absence and presence of immunosuppressant ligands. Biochim. Biophys. Acta. 1994;1209:24–32. doi: 10.1016/0167-4838(94)90132-5. [DOI] [PubMed] [Google Scholar]
- 48.Griffith J. P., Kim J. L., Kim E. E., Sintchak M. D., Thomson J. A., Fitzgibbon M. J., Fleming M. A., Caron P. R., Hsiao K., Navia M. A. X-ray structure of calcineurin inhibited by the immunophilin–immunosuppressant FKBP12–FK506 complex. Cell. 1995;82:507–522. doi: 10.1016/0092-8674(95)90439-5. [DOI] [PubMed] [Google Scholar]
- 49.Liang J., Choi J., Clardy J. Refined structure of the FKBP12–rapamycin–FRB ternary complex at 2.2 Å resolution. Acta Crystallogr., Sect. D: Biol. Crystallogr. 1999;55:736–744. doi: 10.1107/s0907444998014747. [DOI] [PubMed] [Google Scholar]
- 50.Huse M., Chen Y. G., Massague J., Kuriyan J. Crystal structure of the cytoplasmic domain of the type I TGF-β receptor in complex with FKBP12. Cell. 1999;96:425–436. doi: 10.1016/s0092-8674(00)80555-3. [DOI] [PubMed] [Google Scholar]
- 51.Storer C. L., Dickey C. A., Galigniana M. D., Rein T., Cox M. B. FKBP51 and FKBP52 in signaling and disease. Trends Endocrinol. Metab. 2011;22:481–490. doi: 10.1016/j.tem.2011.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Jeener J., Meier B. H., Bachmann P., Ernst R. R. Investigation of exchange processes by two-dimensional NMR spectroscopy. J. Chem. Phys. 1979;71:4546–4553. [Google Scholar]
- 53.Main E. R. G., Fulton K. F., Jackson S. E. Folding pathway of FKBP12 and characterization of the transition state. J. Mol. Biol. 1999;291:429–444. doi: 10.1006/jmbi.1999.2941. [DOI] [PubMed] [Google Scholar]
- 54.Otting G., Liepinsh E., Wüthrich K. Disulfide bond isomerization in BPTI and BPTI (G36S): an NMR study of correlated mobility in proteins. Biochemistry. 1993;32:3571–3582. doi: 10.1021/bi00065a008. [DOI] [PubMed] [Google Scholar]
- 55.Sørensen M. D., Kristensen S. M., Bjørn S., Norris K., Olsen O., Led J. J. Elucidation of the origin of multiple conformations of the human α3-chain type VI collagen C-terminal Kunitz domain: the reorientation of the Trp21 ring. J. Biomol. NMR. 1996;8:391–403. doi: 10.1007/BF00228142. [DOI] [PubMed] [Google Scholar]
- 56.Song J. M., Laskowski J., Qasim M. A., Markley J. L. Two conformational states of turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics. Biochemistry. 2003;42:6380–6391. doi: 10.1021/bi034053f. [DOI] [PubMed] [Google Scholar]
- 57.Sarkar P., Reichman C., Saleh T., Birge R. B., Kalodimos C. G. Proline cis–trans isomerization controls autoinhibition of a signaling protein. Mol. Cell. 2007;25:413–426. doi: 10.1016/j.molcel.2007.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Siemon I. Z., Wieland T., Pook K. H. Influence of the distance of the proline carbonyl from the β and γ carbon on the 13C chemical shifts. Angew. Chem. Int. Ed. 1975;14:702–703. doi: 10.1002/anie.197507021. [DOI] [PubMed] [Google Scholar]
- 59.Schubert M., Labudde D., Oschkinat H., Schmieder P. A software tool for the prediction of Xaa-Pro peptide bond conformations in proteins based on 13C chemical shift statistics. J. Biomol. NMR. 2002;24:149–154. doi: 10.1023/a:1020997118364. [DOI] [PubMed] [Google Scholar]
- 60.Shen Y., Delaglio F., Cornilescu G., Bax A. TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J. Biomol. NMR. 2009;44:213–223. doi: 10.1007/s10858-009-9333-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Itoh S., DeCenzo M. T., Livingston D. J., Pearlman D. A., Navia M. A. Conformation of FK506 in X-ray structures of its complexes with human recombinant FKBP12 mutants. Bioorg. Med. Chem. Lett. 1995;5:1983–1988. [Google Scholar]
- 62.Alexandrescu A. T., Hinck A. P., Markley J. L. Coupling between local structure and global stability of a protein: mutants of staphylococcal nuclease. Biochemistry. 1990;29:4516–4525. doi: 10.1021/bi00471a003. [DOI] [PubMed] [Google Scholar]
- 63.Garrett D. S., Seok Y. J., Peterofsky A., Clore G. M., Gronenborn A. M. Identification by NMR of the binding surface for the histidine-containing phosphocarrier protein HPr on the N-terminal domain of enzyme I of the Escherichia coli phosphotransferase system. Biochemistry. 1997;36:4393–4398. doi: 10.1021/bi970221q. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.